Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

The average one-year price target for MAIA Biotechnology (NYSEAM:MAIA) has been revised to $10.48 / share. This is a decrease ...

A surge in deals and financings had the industry abuzz heading into this year’s J.P. Morgan Healthcare Conference. But some ...

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...

Venture capitalists point to a surge in M&A and a glint of revival in the IPO arena as signs of better days ahead.

Eastern North Carolina's biomanufacturing sector is experiencing unprecedented growth, with the region capturing the lion's ...

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...

Explore India's potential in futuristic marine and space biotechnology to enhance biomanufacturing and strengthen its ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...